MADURAI, India -- Pharmaceutical companies in India are introducing new drugs to treat the growing problem of antimicrobial resistance (AMR), which is one of the top threats to global public health.
Pharmaceuticals
Indian drugmakers to launch new products to counter superbugs
Generics superpower shifting focus to innovation
Doctors in India have seen a disturbing rise in carbapenem resistance since 2012. Carbapenem are a class of powerful antibiotics seen as a last line of defense against drug-resistant bacteria. © AP
Read Next
Latest on Pharmaceuticals
